The journal of vascular access · 2025
Early experience with CELT ACD vascular access closure device for neurointerventional procedures.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dalkilic Ahmet K, Koneru Manisha, Charcos Iris, Santucci Joshua, Ballout Ahmad A, Khalife Jane, Shaikh Hamza A, Patel Pratit D, Thomas Ajith J, Jovin Tudor G, Tonetti Daniel A
Аннотация
INTRODUCTION: The CELT ACD (Vasorum Ltd, Dublin, Ireland) is an access closure device achieving hemostasis with a steel radiopaque structure deployed into the arterial wall without sheath exchange. There is limited data regarding its use in neurointerventional procedures, particularly with larger arteriotomies.
METHODS: A prospective registry of neurointerventional procedures at a single center between July 2024 and February 2025 was retrospectively reviewed. Consecutive transfemoral cases with 6, 7, and 8F sheaths undergoing closure with a newly-deployed 6 or 7F CELT were included. The primary outcomes were rates of device failure and access site complications.
RESULTS: Of 116 patients, there were 119 CELT closures. Successful deployment occurred in 98.3% (117/119). Other than a small groin hematoma (0.8%; 1/119), there were no other access site-related complications reported.
CONCLUSION: This early experience suggests favorable performance and minimal complications with CELT in neurointerventional procedures with larger arteriotomies.
METHODS: A prospective registry of neurointerventional procedures at a single center between July 2024 and February 2025 was retrospectively reviewed. Consecutive transfemoral cases with 6, 7, and 8F sheaths undergoing closure with a newly-deployed 6 or 7F CELT were included. The primary outcomes were rates of device failure and access site complications.
RESULTS: Of 116 patients, there were 119 CELT closures. Successful deployment occurred in 98.3% (117/119). Other than a small groin hematoma (0.8%; 1/119), there were no other access site-related complications reported.
CONCLUSION: This early experience suggests favorable performance and minimal complications with CELT in neurointerventional procedures with larger arteriotomies.